Christoph Schimmer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christoph Schimmer has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian-Patrick Sommer
Department of Cardiothoracic and Thoracic Vascular Surgery, University Hospital Würzburg, Würzburg, Germany
7 shared publications Armin Gorski
Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
5 shared publicationsR. Leyh
Universitätsklinikum Würzburg, Zentrum Operative Medizin
5 shared publications- Rainer Leyh
Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
5 shared publications Rainer Leyh
Department of Cardiothoracic and Thoracic Vascular Surgery, University Hospital Würzburg, Würzburg, Germany
4 shared publications- Ivan Aleksic
Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
3 shared publications
Latest Publications
- 3 May 2017
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 31 (3) , 161-168
„Negative pressure wound therapy“ bei sternalen Wundinfektionen
- 3 May 2017
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 31 (3) , 161-168
„Negative pressure wound therapy“ bei sternalen Wundinfektionen
- 12 June 2015
- Published by Springer Nature in Medizinische Klinik - Intensivmedizin und Notfallmedizin
- Vol. 111 (2) , 92-97
Begrenzung und Abbruch lebenserhaltender Maßnahmen bei kritisch kranken kardiochirurgischen Patienten
Ethische und medizinische Kriterien der Entscheidungsfindung bezüglich Therapiebegrenzung oder Therapieabbruch von lebenserhaltenden Maßnahmen bei kritisch kranken Patienten stellen eine große Herausforderung in der Intensivmedizin dar. Welche medizinischen und ethischen Kriterien sind bei kritisch kranken kardiochirurgischen Patienten bei der Entscheidungsfindung zur Therapiezieländerung mitentscheidend? Es wurde eine Fragebogenevaluierung bei allen deutschen herzchirurgischen Zentren (n = 79) durchgeführt. Befragt wurden jeweils der Klinikdirektor, der Oberarzt und die Pflegeleitung der Intensivstation (n = 237 Fragebögen). Es wurden 86 von 237 (36,3 %) Fragebögen beantwortet. Medizinische Gründe, die bei der Entscheidungsfindung zur Therapiezieländerung (Therapiebegrenzung und Therapieabbruch) beitragen, waren: kraniale Computertomographie (CCT) mit infauster Prognose (91,9 %), Multiorganversagen (70,9 %) und Versagen einer kardialen Assist-Device-Therapie (69,8 %). Bezüglich der ethischen Kriterien wurden eine schlechte Lebensqualität (48,8 %) sowie der mutmaßliche Patientenwille (40,7 %) angegeben. Die 3 unterschiedlichen Berufsgruppen zeigten sowohl bei der Beurteilung einiger medizinischer und ethischer Kriterien als auch in der Involvierung in den Entscheidungsprozess signifikante Unterschiede. Medizinische Gründe, die bei kritisch kranken kardiochirurgischen Patienten bei der Entscheidungsfindung zur Therapiezieländerung mit ausschlaggebend sind, waren eine CCT mit infauster Prognose, ein Multiorganversagen und ein Versagen einer kardialen Assist-Device-Therapie. Weitere Studien sind notwendig, um diese schwerwiegende Fragestellung zufriedenstellend beantworten zu können. Ethical and medical criteria in the decision-making process of withholding or withdrawal of life support therapy in critically ill patients present a great challenge in intensive care medicine. The purpose of this work was to assess medical and ethical criteria that influence the decision-making process for changing the aim of therapy in critically ill cardiac surgery patients. A questionnaire was distributed to all German cardiac surgery centers (n = 79). All clinical directors, intensive care unit (ICU) consultants and ICU head nurses were asked to complete questionnaires (n = 237). In all, 86 of 237 (36.3 %) questionnaires were returned. Medical reasons which influence the decision-making process for changing the aim of therapy were cranial computed tomography (cCT) with poor prognosis (91.9 %), multi-organ failure (70.9 %), and failure of assist device therapy (69.8 %). Concerning ethical reasons, poor expected quality of life (48.8 %) and the presumed patient's wishes (40.7 %) were reported. There was a significant difference regarding the perception of the three different professional groups concerning medical and ethical criteria as well as the involvement in the decision-making process. In critically ill cardiac surgery patients, medical reasons which influence the decision-making process for changing the aim of therapy included cCT with poor prognosis, multi-organ failure, and failure of assist device therapy. Further studies are mandatory in order to be able to provide adequate answers to this difficult topic.
- 12 June 2015
- Published by Springer Nature in Medizinische Klinik - Intensivmedizin und Notfallmedizin
- Vol. 111 (2) , 92-97
Begrenzung und Abbruch lebenserhaltender Maßnahmen bei kritisch kranken kardiochirurgischen Patienten
Ethische und medizinische Kriterien der Entscheidungsfindung bezüglich Therapiebegrenzung oder Therapieabbruch von lebenserhaltenden Maßnahmen bei kritisch kranken Patienten stellen eine große Herausforderung in der Intensivmedizin dar. Welche medizinischen und ethischen Kriterien sind bei kritisch kranken kardiochirurgischen Patienten bei der Entscheidungsfindung zur Therapiezieländerung mitentscheidend? Es wurde eine Fragebogenevaluierung bei allen deutschen herzchirurgischen Zentren (n = 79) durchgeführt. Befragt wurden jeweils der Klinikdirektor, der Oberarzt und die Pflegeleitung der Intensivstation (n = 237 Fragebögen). Es wurden 86 von 237 (36,3 %) Fragebögen beantwortet. Medizinische Gründe, die bei der Entscheidungsfindung zur Therapiezieländerung (Therapiebegrenzung und Therapieabbruch) beitragen, waren: kraniale Computertomographie (CCT) mit infauster Prognose (91,9 %), Multiorganversagen (70,9 %) und Versagen einer kardialen Assist-Device-Therapie (69,8 %). Bezüglich der ethischen Kriterien wurden eine schlechte Lebensqualität (48,8 %) sowie der mutmaßliche Patientenwille (40,7 %) angegeben. Die 3 unterschiedlichen Berufsgruppen zeigten sowohl bei der Beurteilung einiger medizinischer und ethischer Kriterien als auch in der Involvierung in den Entscheidungsprozess signifikante Unterschiede. Medizinische Gründe, die bei kritisch kranken kardiochirurgischen Patienten bei der Entscheidungsfindung zur Therapiezieländerung mit ausschlaggebend sind, waren eine CCT mit infauster Prognose, ein Multiorganversagen und ein Versagen einer kardialen Assist-Device-Therapie. Weitere Studien sind notwendig, um diese schwerwiegende Fragestellung zufriedenstellend beantworten zu können. Ethical and medical criteria in the decision-making process of withholding or withdrawal of life support therapy in critically ill patients present a great challenge in intensive care medicine. The purpose of this work was to assess medical and ethical criteria that influence the decision-making process for changing the aim of therapy in critically ill cardiac surgery patients. A questionnaire was distributed to all German cardiac surgery centers (n = 79). All clinical directors, intensive care unit (ICU) consultants and ICU head nurses were asked to complete questionnaires (n = 237). In all, 86 of 237 (36.3 %) questionnaires were returned. Medical reasons which influence the decision-making process for changing the aim of therapy were cranial computed tomography (cCT) with poor prognosis (91.9 %), multi-organ failure (70.9 %), and failure of assist device therapy (69.8 %). Concerning ethical reasons, poor expected quality of life (48.8 %) and the presumed patient's wishes (40.7 %) were reported. There was a significant difference regarding the perception of the three different professional groups concerning medical and ethical criteria as well as the involvement in the decision-making process. In critically ill cardiac surgery patients, medical reasons which influence the decision-making process for changing the aim of therapy included cCT with poor prognosis, multi-organ failure, and failure of assist device therapy. Further studies are mandatory in order to be able to provide adequate answers to this difficult topic.
- Open Access
- 26 February 2015
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 10 (1) , 25
Different duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study
All international guidelines recommend perioperative antibiotic prophylaxis (PAB) should be routinely administered to patients undergoing cardiac surgery. However, the duration of PAB is heterogeneous and controversial. Between 01.01.2011 and 31.12.2011, 1096 consecutive cardiac surgery patients were assigned to one of two groups receiving PAB with a second-generation cephalosporin for either 56 h (group I) or 32 h (group II). Patients’ characteristics, intraoperative data, and the in-hospital follow-up were analysed. Primary endpoint was the incidence of surgical site infection (deep and superficial sternal wound-, and vein harvesting site infection; DSWI/SSWI/VHSI). Secondary endpoints were the incidence of respiratory-, and urinary tract infection, as well as the mortality rate. 615/1096 patients (56,1%) were enrolled (group I: n = 283 versus group II: n = 332). There were no significant differences with regard to patient characteristics, comorbidities, and procedure-related variables. No statistically significant differences were demonstrated concerning primary and secondary endpoints. The incidence of DSWI/SSWI/VHSI were 4/283 (1,4%), 5/283 (1,7%), and 1/283 (0,3%) in group I versus 6/332 (1,8%), 9/332 (2,7%), and 3/332 (0,9%) in group II (p = 0,76/0,59/0,63). In univariate analyses female gender, age, peripheral arterial obstructive disease, operating-time, ICU-duration, transfusion, and respiratory insufficiency were determinants for nosocomial infections (all ≤ 0,05). Subgroup analyses of these high-risk patients did not show any differences between the two regimes (all ≥ 0,05). Reducing the duration of PAB from 56 h to 32 h in adult cardiac surgery patients was not associated with an increase of nosocomial infection rate, but contributes to reduce antibiotic resistance and health care costs.
- 26 February 2015
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 10 (1) , 25
Open AccessDifferent duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study
All international guidelines recommend perioperative antibiotic prophylaxis (PAB) should be routinely administered to patients undergoing cardiac surgery. However, the duration of PAB is heterogeneous and controversial. Between 01.01.2011 and 31.12.2011, 1096 consecutive cardiac surgery patients were assigned to one of two groups receiving PAB with a second-generation cephalosporin for either 56 h (group I) or 32 h (group II). Patients’ characteristics, intraoperative data, and the in-hospital follow-up were analysed. Primary endpoint was the incidence of surgical site infection (deep and superficial sternal wound-, and vein harvesting site infection; DSWI/SSWI/VHSI). Secondary endpoints were the incidence of respiratory-, and urinary tract infection, as well as the mortality rate. 615/1096 patients (56,1%) were enrolled (group I: n = 283 versus group II: n = 332). There were no significant differences with regard to patient characteristics, comorbidities, and procedure-related variables. No statistically significant differences were demonstrated concerning primary and secondary endpoints. The incidence of DSWI/SSWI/VHSI were 4/283 (1,4%), 5/283 (1,7%), and 1/283 (0,3%) in group I versus 6/332 (1,8%), 9/332 (2,7%), and 3/332 (0,9%) in group II (p = 0,76/0,59/0,63). In univariate analyses female gender, age, peripheral arterial obstructive disease, operating-time, ICU-duration, transfusion, and respiratory insufficiency were determinants for nosocomial infections (all ≤ 0,05). Subgroup analyses of these high-risk patients did not show any differences between the two regimes (all ≥ 0,05). Reducing the duration of PAB from 56 h to 32 h in adult cardiac surgery patients was not associated with an increase of nosocomial infection rate, but contributes to reduce antibiotic resistance and health care costs.
- 18 February 2015
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 64 (04) , 304-310
Degree of Carotid Artery Stenosis in Neurologically Asymptomatic Cardiac Surgical Patients Suffering from Perioperative Stroke: Results of an Observational Study
Background Postoperative stroke in cardiac surgical patients remains a serious adverse outcome. Methods A total of 2,784 consecutively operated cardiac surgical patients without preoperative neurologic impairment were analyzed retrospectively with regard to impact of preoperative carotid stenosis on the incidence of postprocedural new onset of stroke. Therefore, all analyzed patients were assigned to four groups depending on preoperative degree of carotid artery stenosis detected by carotid duplex sonography (group I: < 50%, group II: 50–75%, group III: 76–89%, and group IV: > 90%). Results All pre-, intra-, and postoperative risk factors for neurological disorders were comparable throughout the cohort. Of the 2,784 patients, 65 (2.3%) met the inclusion criteria (preoperatively neurologically asymptomatic status, preoperatively carotid duplex ultrasonography study not older than 6 months, heart surgery with extracorporeal circulation, stroke until 48 hours after operation). Of the 65 patients who met the inclusion criteria, 43 (66.2%) were in group I, 11 (16.9%) in group II, 5 (7.7%) in group III, and 6 (9.2%) in group IV (p = 0.175). The overall incidence of an ipsilateral stroke relating to the carotid stenosis was 38 (1.4%) patients. Of these, 27 (71.1%) patients were in group I, 6 (15.8%) patients in group II, 2 (5.3%) patients in group III, and 3 (7.9%) patients in group IV (p = 0.568). Conclusion This observational study demonstrates that the degree of carotid stenosis in neurologically asymptomatic cardiac surgical patients is not able to predict the probability of perioperative stroke. Until further results from prospective randomized trials with neurologically asymptomatic cardiac surgical patients are presented, a cautious attitude for concomitant carotid endarterectomy is still justified.
- 18 February 2015
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 64 (04) , 304-310
Degree of Carotid Artery Stenosis in Neurologically Asymptomatic Cardiac Surgical Patients Suffering from Perioperative Stroke: Results of an Observational Study
Background Postoperative stroke in cardiac surgical patients remains a serious adverse outcome. Methods A total of 2,784 consecutively operated cardiac surgical patients without preoperative neurologic impairment were analyzed retrospectively with regard to impact of preoperative carotid stenosis on the incidence of postprocedural new onset of stroke. Therefore, all analyzed patients were assigned to four groups depending on preoperative degree of carotid artery stenosis detected by carotid duplex sonography (group I: < 50%, group II: 50–75%, group III: 76–89%, and group IV: > 90%). Results All pre-, intra-, and postoperative risk factors for neurological disorders were comparable throughout the cohort. Of the 2,784 patients, 65 (2.3%) met the inclusion criteria (preoperatively neurologically asymptomatic status, preoperatively carotid duplex ultrasonography study not older than 6 months, heart surgery with extracorporeal circulation, stroke until 48 hours after operation). Of the 65 patients who met the inclusion criteria, 43 (66.2%) were in group I, 11 (16.9%) in group II, 5 (7.7%) in group III, and 6 (9.2%) in group IV (p = 0.175). The overall incidence of an ipsilateral stroke relating to the carotid stenosis was 38 (1.4%) patients. Of these, 27 (71.1%) patients were in group I, 6 (15.8%) patients in group II, 2 (5.3%) patients in group III, and 3 (7.9%) patients in group IV (p = 0.568). Conclusion This observational study demonstrates that the degree of carotid stenosis in neurologically asymptomatic cardiac surgical patients is not able to predict the probability of perioperative stroke. Until further results from prospective randomized trials with neurologically asymptomatic cardiac surgical patients are presented, a cautious attitude for concomitant carotid endarterectomy is still justified.
- 1 January 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (1) , 328-9
The pros and cons of intensive insulin therapy.
- 1 January 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (1) , 328-9
The pros and cons of intensive insulin therapy.
- 24 July 2014
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 23 (3) , 282-288
Cardiac surgery antibiotic prophylaxis and calculated empiric antibiotic therapy
Background: Ongoing debate exists concerning the optimal choice and duration of antibiotic prophylaxis as well as the reasonable calculated empiric antibiotic therapy for hospital-acquired infections in critically ill cardiac surgery patients. Methods: A nationwide questionnaire was distributed to all German heart surgery centers concerning antibiotic prophylaxis and the calculated empiric antibiotic therapy. Results: The response to the questionnaire was 87.3%. All clinics that responded use antibiotic prophylaxis, 79% perform it not longer than 24 h (single-shot: 23%; 2 doses: 29%; 3 doses: 27%; 4 doses: 13%; and >5 doses: 8%). Cephalosporin was used in 89% of clinics (46% second-generation, 43% first-generation cephalosporin). If sepsis is suspected, the following diagnostics are performed routinely: wound inspection 100%; white blood cell count 100%; radiography 99%; C-reactive protein 97%; microbiological testing of urine 91%, blood 81%, and bronchial secretion 81%; procalcitonin 74%; and echocardiography 75%. The calculated empiric antibiotic therapy (depending on the suspected focus) consists of a multidrug combination with broad-spectrum agents. Conclusion: This survey shows that existing national guidelines and recommendations concerning perioperative antibiotic prophylaxis and calculated empiric antibiotic therapy are well applied in almost all German heart centers.
- 24 July 2014
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 23 (3) , 282-288
Cardiac surgery antibiotic prophylaxis and calculated empiric antibiotic therapy
Background: Ongoing debate exists concerning the optimal choice and duration of antibiotic prophylaxis as well as the reasonable calculated empiric antibiotic therapy for hospital-acquired infections in critically ill cardiac surgery patients. Methods: A nationwide questionnaire was distributed to all German heart surgery centers concerning antibiotic prophylaxis and the calculated empiric antibiotic therapy. Results: The response to the questionnaire was 87.3%. All clinics that responded use antibiotic prophylaxis, 79% perform it not longer than 24 h (single-shot: 23%; 2 doses: 29%; 3 doses: 27%; 4 doses: 13%; and >5 doses: 8%). Cephalosporin was used in 89% of clinics (46% second-generation, 43% first-generation cephalosporin). If sepsis is suspected, the following diagnostics are performed routinely: wound inspection 100%; white blood cell count 100%; radiography 99%; C-reactive protein 97%; microbiological testing of urine 91%, blood 81%, and bronchial secretion 81%; procalcitonin 74%; and echocardiography 75%. The calculated empiric antibiotic therapy (depending on the suspected focus) consists of a multidrug combination with broad-spectrum agents. Conclusion: This survey shows that existing national guidelines and recommendations concerning perioperative antibiotic prophylaxis and calculated empiric antibiotic therapy are well applied in almost all German heart centers.
- 1 July 2013
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (2) , e30-e32
Alcohol septal ablation for recurrent left ventricular outflow tract obstruction after combined myectomy and mitral valve repair in hypertrophic cardiomyopathy
- 1 July 2013
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (2) , e30-e32
Alcohol septal ablation for recurrent left ventricular outflow tract obstruction after combined myectomy and mitral valve repair in hypertrophic cardiomyopathy
- 1 September 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (3) , 742-743
Reply to the Editor
- 1 September 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (3) , 742-743
Reply to the Editor
- 15 January 2012
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 26 (1) , 41-47
Das Mediastinitisregister
- 15 January 2012
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 26 (1) , 41-47
Das Mediastinitisregister
- 1 January 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 143 (1) , 194-200
Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: A controlled, prospectively randomized, double-blind study
- 1 January 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 143 (1) , 194-200
Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: A controlled, prospectively randomized, double-blind study